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Vitamin D and Diabetic Foot
Antony Macido
Abstract
Approximately 15% of patients with diabetes mellitus (DM) are prone to 
developing diabetic foot ulcers (DFU) in their lifetime. The term vitamin D status 
or 25-hydroxyvitamin D [25(OH)D] levels are used interchangeably to represent 
the status of vitamin D in individuals throughout this paper. Evidence suggests 
a relationship between 25(OH)D levels and DFU. However, very minimal data 
is available on the association between DFU and vitamin D deficiency. After a 
careful review of the literature, it was inferred that vitamin D could be associated 
with DFU and diabetic foot infections. Available evidence on vitamin D and DFU 
suggests a negative correlation between 25(OH)D levels and the presence of DFU. 
Evidence also supports a negative relationship between 25(OH)D levels and diabetic 
foot infections. Further large-scale randomized controlled studies need to be done 
to confirm the relationship between 25(OH)D levels and DFU including the use of 
vitamin D in the management of DFU and diabetic foot infections.
Keywords: Vitamin D, 1,25-dihydroxyvitamin D, diabetic foot ulcers, diabetic foot 
infections
1. Introduction
The role of serum vitamin D in diabetes mellitus (DM) and in the complica-
tions related to DM is an area of interest among researchers in the recent past [1, 
2]. Diabetic foot complications including diabetic foot ulcers (DFU) and diabetic 
foot infections are often common with vitamin D deficiency [3]. The global preva-
lence of diabetic foot complication is 6.3% [4]. Almost 15% of patients with DM 
can develop DFU in their lives [1]. Infection of DFU is one of the common causes 
of hospitalization related to DM and accounts for 20% of admissions to hospitals 
[5]. Recurrence rates are very high with DFU although the recurrence rates have 
decreased recently [6].
DFU accounts for growing economic burden, while increasing the morbidity 
and mortality globally. It is estimated that the global economic burden of caring for 
DFU is more than $1.5 billion per year [7]. Every 30 seconds someone loses a lower 
extremity from DM in the world [8]. The five-year mortality in patients with DFU 
is 2.5 times higher than patients with DM but has no DFU [9].
There is growing evidence on the relationship between DFU and vitamin D 
levels. Nevertheless, data is scarce on the association between vitamin D deficiency 
and DFU [2]. Evidence suggests a negative correlation between DFU and vitamin 
D levels. There is growing evidence on a negative relationship between diabetic 
foot infections and vitamin D levels. Further large-scale randomized controlled 
studies are needed to solidify the evidence of the correlation between DFU and 
Vitamin D
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vitamin D levels. Before evaluating the significance of vitamin D in diabetic foot 
complications it is essential to review the effects of vitamin D in diabetic foot 
complications including the non-skeletal effects of vitamin D.
2. Non-skeletal effects of vitamin D
Vitamin D is a fat-soluble vitamin that has effects that are not confined to the 
skeleton. Vitamin D aids in glucose metabolism, angiogenesis, and migration of 
inflammatory cells [10]. 1,25-(OH)2D is the active form of vitamin D and it acts as a 
ligand for an intracellular receptor and transcription factor VDR [11, 12]. Vitamin D 
in the form of 1,25-(OH)2D exerts prodifferentiative and antiproliferative effects on 
the cutaneous keratinocytes [13], which in turn helps in defense against toxins and 
pathogens while helping to prevent water loss from the skin [11]. Vitamin D recep-
tor is essential for differentiation, migration, and self-renewal of epidermal stem 
cells in wound healing [14].
3. Diabetic foot ulcers
International Working Group on the Diabetic Foot (IWGDF) defines DFU as a 
foot ulcer in persons with previously diagnosed or currently diagnosed DM and is 
usually accompanied by peripheral artery disease (PAD) and/or neuropathy in the 
lower extremity. Diabetic foot is defined as an ulceration, infection, or destruction 
of tissues of the foot of an individual with previously or currently diagnosed DM, 
usually accompanied by PAD and/or neuropathy in the lower extremity. A foot 
ulcer involves a break of the skin of the foot involving the entire epidermis and the 
dermis in part [15]. Diabetic foot ulcers can be located in different areas of the foot. 
Almost 25% of DFU are plantar ulcers that are localized to the forefoot [16].
4. Risk factors for developing DFU
Peripheral vascular disease and diabetic neuropathy are the important risk 
factors associated with the development of DFU [17]. Foot deformities and prior 
history of DFU are also risk factors associated with the development of DFU [18]. 
Inflammation along with oxidative stress have been postulated in the development 
of DFU [19]. Vitamin D deficiency is labeled as an independent risk factor in the 
development of diabetic neuropathy [20].
5.  Vitamin D deficiency as a risk factor for diabetic foot  
ulcers/infections
Significantly low levels of vitamin D can be seen with diabetic foot complica-
tions [3]. Although vitamin D deficiency is common in DM, the magnitude of 
hypovitaminosis D is noticed to be more significant with infected DFU [21–23]. 
Vitamin D deficiency can in turn increase inflammatory cytokines and delay wound 
healing in patients with DFU [23]. An antimicrobial peptide called cathelicidin 
has an important role in wound healing process [24, 25]. In fact, 1,25-(OH)2D can 
increase the genes capable of inducing cathelicidin production [26]. The literature 
on vitamin D deficiency and diabetic foot can be synthesized as follows.
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6. Literature review
Although there is literature available on the association between vitamin D and 
diabetic foot, only a few randomized controlled studies and metanalyses are avail-
able. A metanalysis by Iannuzzo et al. [27] reported that vitamin D deficiency was 
associated with PAD and may be an independent risk factor for developing PAD. 
Adults with diabetes and severe vitamin D deficiency are three times more likely to 
develop a diabetic foot ulcer than similar patients with sufficient vitamin D levels 
[28]. The Dai et al. [28] study is the first meta-analysis demonstrating the associa-
tion between serum vitamin D levels and DFU.
A double-blind, randomized controlled clinical trial by Razzaghi et al. [29] 
showed that vitamin D supplementation can aid in the healing of DFU possibly 
from its effect of improved glycemic control. The study revealed reasonable 
decrease in ulcer depth, width, and length in the experiment group with vitamin D 
therapy [29]. The Tiwari et al. [22] study identified a cutoff value for vitamin D 
levels (25(OH)D < 25 nmol/l) in diabetic patients that put them at risk to develop 
diabetic foot infections. The study was a prospective cohort research but not 
randomized. Another non-randomized prospective cohort hospital-based study by 
Zubair et al. [2] revealed that patients with DFU had a median lower plasma level of 
25(OH)D than the control group.
There is more than a dozen of other non-randomized studies that evaluated the 
prevalence of vitamin D deficiency and the potential use of vitamin D in diabetic 
foot complications. Majority of these studies reported low vitamin D levels in 
patients with DFU when compared to their counterparts with no DFU [3]. This 
strong association between vitamin D deficiency and DFU may not imply causation 
or correlation. However, this relationship of vitamin D deficiency and the presence 
of DFU may have implications in the clinical management of DFU [3]. Surprisingly, 
a study by Afarideh et al. [30] revealed increased levels of circulating 25 (OH)D 
with active chronic DFU. The authors claim that this is the only study that showed 
the conflicting finding of increased vitamin D levels in patients with DFU [30].
7. Vitamin D deficiency and supplementation
According to The Endocrine Society, vitamin D deficiency implies a serum 
25(OH)D of less than 20 nanograms per milliliter (ng/ml). The recommended assay 
for diagnosing vitamin D deficiency is the measurement of serum 25(OH)D.  
Vitamin D deficiency can be treated with either vitamin D3 or vitamin D2 [31]. 
Vitamin D supplementation needs to be tailored according to the age, sex, pres-
ence of comorbidities, etc. Vitamin D deficiency in adults need to be treated with 
50,000 IU of vitamin D2 or D3 once a week for a duration of eight weeks or its 
equivalent vitamin D2 or vitamin D3 as daily doses to achieve a serum 25 (OH)
D level of more than 30 ng/ml, followed by 1500–2000 IU daily for maintenance 
therapy [31]. There are no current recommendations on vitamin D dosage for 
individuals with DM or individuals with DFU who also have vitamin D deficiency.
8. Conclusion
There is insufficient data on the significance of vitamin D in DFU. There are no 
guidelines or standardized measures available on routine evaluation of vitamin D 





Keck Medical Center of USC, University of Southern California, 
Los Angeles, California, USA
*Address all correspondence to: amacido@gmail.com
DM and DFU do not comment on the recommendations on vitamin D use in the 
prevention and treatment of DFU. Literature does not support the routine use of 
vitamin D in the treatment and prevention of diabetic foot infections. The literature 
available on the different types of DM and the role of vitamin D in the development 
of DFU is scarce. Further research is needed to confirm the relationship between 
DFU and vitamin D including the use of vitamin D in the management of DFU and 
diabetic foot infections. Provided the beneficial effects on wound healing, identi-
fication and treatment of vitamin D deficiency could improve or prevent diabetic 
foot complication outcomes [3]. Despite the lack of strong evidence to recommend-
ing vitamin D in DM and DFU, routine vitamin D supplements in patients with DM 
and DFU should be considered for its other benefits.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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